MIRA
MIRA PHARMACEUTICALS, INC.Company Information
- Company Name
- MIRA PHARMACEUTICALS, INC.
- CIK
- CIK0001904286
- Category
- <br>Emerging growth company
- Ticker: Exchange
- MIRA: Nasdaq
- Fiscal Year End
- N/A
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- MIRA
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-05-21
- Last sale
- 2025-10-16
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 658,185
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,300,813
- Shares outstanding
- 42,022,087
- Ownership
- 5.48%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 3.38%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 5 | 6 | 3 | 1 | 1 | 3 | 4 | 3 | 4 | 5 | 6 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 8 | 9 | 11 | 8 | 1 | 1 | 3 | 4 | 3 | 4 | 5 | 6 | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Short Term Investments | 5 | 5 | 5 | 5 | - | - | - | - | - | - | - | - | ||||||
| Deferred Finance Costs Net | - | - | - | - | - | - | - | - | - | - | - | 3 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | - | 0 | 0 | - | ||||||
| Other Receivables | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Assets | 8 | 9 | 11 | 8 | 1 | 1 | 3 | 4 | 3 | 4 | 5 | 9 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | - | - | - | 0 | 0 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | - | - | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Other Liabilities Current | - | - | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 50 | 50 | 50 | 41 | 33 | 32 | 31 | 30 | 27 | 26 | 26 | 24 | ||||||
| Stockholders Equity | 8 | 9 | 10 | 8 | 1 | 1 | 2 | 4 | 2 | 3 | 4 | 8 | ||||||
| Retained Earnings Accumulated Deficit | -42 | -41 | -40 | -34 | -32 | -31 | -29 | -27 | -25 | -23 | -21 | -15 | ||||||
| Liabilities And Stockholders Equity | 8 | 9 | 11 | 8 | 1 | 1 | 3 | 4 | 3 | 4 | 5 | 9 | ||||||
| Preferred Stock No Par Value | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock No Par Value | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 42 | 42 | 42 | 40 | 17 | 17 | 17 | 16 | 15 | 15 | 15 | 15 | ||||||
| Shares Outstanding | 42 | 42 | 42 | 40 | 17 | 17 | 17 | 16 | 15 | 15 | 15 | 15 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMIRA PHARMACEUTICALS, INC. (MIRA) — SEC Financial Statements & Analysis
MIRA PHARMACEUTICALS, INC. (MIRA) is a pharmaceutical preparations company, incorporated in FL. MIRA PHARMACEUTICALS, INC. trades on Nasdaq as: MIRA. MIRA PHARMACEUTICALS, INC. (MIRA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, MIRA PHARMACEUTICALS, INC. carries a market cap of $39.79M, a P/E ratio of -1.28x, a P/B ratio of 4.88x, a P/S ratio of 5282.79x, an enterprise value of $36.19M, and an EV/EBITDA multiple of -1.16x. On profitability, it posts an operating margin of 0.00%, a net margin of -369225.18%, a Return on Equity (ROE) of -710.85%, a Return on Assets (ROA) of -684.27%, and a Return on Invested Capital (ROIC) of -1419.96%. Per share, it reports EPS of $-0.74, diluted EPS of $-1.47, free cash flow per share of $-0.11, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 299.69% year-over-year, and EPS growth of 61.57% year-over-year. On the balance sheet, it maintains a current ratio of 200.08x, a quick ratio of 198.75x, working capital of $8.13M, a debt-to-equity ratio of 0.01x, a debt ratio of 0, an interest coverage ratio of -209.43x, free cash flow of $-4.64M (TTM), and net debt of $-3.61M. Figures sourced from SEC EDGAR.
- Market Cap
- $39.79M
- P/E TTM
- -1.28x
- EPS TTM
- $-0.74
- P/B TTM
- 4.88x
- ROE TTM
- -710.85%
- ROA TTM
- -684.27%
- Debt To Equity
- 0.01x
- Free Cash Flow TTM
- $-4.64M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MIRA PHARMACEUTICALS, INC. in?
MIRA PHARMACEUTICALS, INC. (MIRA) operates in the Pharmaceutical Preparations industry.
What exchange does MIRA trade on?
MIRA PHARMACEUTICALS, INC. (MIRA) trades on the Nasdaq.
Where is MIRA PHARMACEUTICALS, INC. incorporated?
MIRA PHARMACEUTICALS, INC. is incorporated in FL.
When was MIRA PHARMACEUTICALS, INC. (MIRA)'s most recent SEC filing?
MIRA PHARMACEUTICALS, INC. (MIRA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is MIRA's market cap?
MIRA PHARMACEUTICALS, INC. (MIRA) has a market capitalization of $39.79M as of 2026-06-30.
What is MIRA's EPS (earnings per share)?
MIRA PHARMACEUTICALS, INC. (MIRA)'s trailing twelve month EPS is $-0.74 as of 2026-06-30.
What is MIRA's ROE (return on equity)?
MIRA PHARMACEUTICALS, INC. (MIRA)'s trailing twelve month Return on Equity (ROE) is -710.85% as of 2026-06-30.
What is MIRA's ROA (return on assets)?
MIRA PHARMACEUTICALS, INC. (MIRA)'s trailing twelve month Return on Assets (ROA) is -684.27% as of 2026-06-30.
What is MIRA's ROIC (return on invested capital)?
MIRA PHARMACEUTICALS, INC. (MIRA)'s trailing twelve month Return on Invested Capital (ROIC) is -1419.96% as of 2026-06-30.
What is MIRA's EV/EBITDA?
MIRA PHARMACEUTICALS, INC. (MIRA)'s trailing twelve month EV/EBITDA is -1.16x as of 2026-06-30.